Routine insulin after pancreas surgery may be unnecessary for some patients
NCT ID NCT07540975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether non-diabetic patients who have pancreas surgery can safely avoid routine insulin afterward. About 290 adults will be randomly assigned to receive either standard insulin or no insulin after surgery. The goal is to see if skipping insulin keeps blood sugar under control while reducing side effects like low blood sugar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan medical center
Seoul, 05505, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New device aims to seal pancreas during robotic surgery, cutting leak risk
- Pancreas removal study tracks diabetes worsening after surgery
- Pancreas removal study to uncover diabetes danger
- Scientists hunt for biomarkers in pancreatic cancer to guide therapy
- New app aims to ease pancreatic cancer care at home
- Heat therapy for pancreatic cancer: a new hope?